Smith & Nephew plc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Smith & Nephew plc trades at $27.23 (market cap $11.10B), while Direxion Daily Semiconductor Bull 3X Shares trades at $138.74 (market cap $24.42B). The key difference: Direxion Daily Semiconductor Bull 3X Shares is far larger — about 2.2× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.95% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| SNN | SOXL | |
|---|---|---|
Market Cap | $11.10B | $24.42B |
Volume | 1,051,703 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $37.17 | $300.77 |
52-Week Low | $26.42 | $30.81 |
Typical Hold Time | 121 Days | 15 Days |
Enterprise Value | $14.13B | — |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.10, near its 52-week low, with a bearish technical signal. The company reported solid fundamentals with revenue growth to $6.16B in 2025 and a net income margin of 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. Cash flow from operations remains strong at $1.29B, though net cash flow was negative $64M in 2025.
The outlook is mixed: strong profitability and innovation support long-term value, but near-term headwinds include analyst downgrades and competitive pressures. Risks involve execution challenges and market sentiment. The stock presents a cautious opportunity for value investors, balancing solid fundamentals against current bearish trends.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $139.3, down 12.34% in the last 24 hours amid semiconductor sector volatility. Technical indicators show a bearish overall signal with mixed moving averages and neutral oscillators. The fund's leveraged structure amplifies both gains and losses in the semiconductor sector, which faces conflicting signals from strong AI demand versus concerns about valuation and regulatory risks.
The outlook for SOXL remains highly volatile, with opportunities tied to sustained AI-driven semiconductor demand but significant risks from the fund's 3x leverage structure and sector-specific headwinds. Investors face amplified exposure to semiconductor stock fluctuations, requiring careful risk management given the current bearish technical setup and mixed market sentiment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →